Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of $106.99 billion. The enterprise value is $122.05 billion.
Important Dates
The next estimated earnings date is Thursday, April 23, 2026, before market open.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
Sanofi has 1.21 billion shares outstanding. The number of shares has decreased by -2.43% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | -2.43% |
| Shares Change (QoQ) | -0.44% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 49.63% |
| Float | 1.08B |
Valuation Ratios
The trailing PE ratio is 5.95 and the forward PE ratio is 8.90.
| PE Ratio | 5.95 |
| Forward PE | 8.90 |
| PS Ratio | 1.95 |
| Forward PS | 2.25 |
| PB Ratio | 1.27 |
| P/TBV Ratio | 7.26 |
| P/FCF Ratio | 10.24 |
| P/OCF Ratio | 8.48 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.23, with an EV/FCF ratio of 11.69.
| EV / Earnings | 13.30 |
| EV / Sales | 2.23 |
| EV / EBITDA | 8.23 |
| EV / EBIT | 10.77 |
| EV / FCF | 11.69 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.09 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.58 |
| Debt / FCF | 2.29 |
| Interest Coverage | 18.17 |
Financial Efficiency
Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 9.35%.
| Return on Equity (ROE) | 6.66% |
| Return on Assets (ROA) | 4.65% |
| Return on Invested Capital (ROIC) | 9.35% |
| Return on Capital Employed (ROCE) | 9.80% |
| Weighted Average Cost of Capital (WACC) | 5.51% |
| Revenue Per Employee | $732,842 |
| Profits Per Employee | $122,564 |
| Employee Count | 74,846 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, Sanofi has paid $1.22 billion in taxes.
| Income Tax | 1.22B |
| Effective Tax Rate | 17.33% |
Stock Price Statistics
The stock price has decreased by -24.68% in the last 52 weeks. The beta is 0.36, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -24.68% |
| 50-Day Moving Average | 47.39 |
| 200-Day Moving Average | 48.68 |
| Relative Strength Index (RSI) | 35.43 |
| Average Volume (20 Days) | 5,149,334 |
Short Selling Information
The latest short interest is 7.94 million, so 0.66% of the outstanding shares have been sold short.
| Short Interest | 7.94M |
| Short Previous Month | 8.34M |
| Short % of Shares Out | 0.66% |
| Short % of Float | 0.73% |
| Short Ratio (days to cover) | 1.76 |
Income Statement
In the last 12 months, Sanofi had revenue of $54.85 billion and earned $9.17 billion in profits. Earnings per share was $7.48.
| Revenue | 54.85B |
| Gross Profit | 39.68B |
| Operating Income | 11.33B |
| Pretax Income | 7.07B |
| Net Income | 9.17B |
| EBITDA | 14.84B |
| EBIT | 11.33B |
| Earnings Per Share (EPS) | $7.48 |
Full Income StatementBalance Sheet
The company has $9.01 billion in cash and $23.87 billion in debt, with a net cash position of -$14.86 billion or -$12.30 per share.
| Cash & Cash Equivalents | 9.01B |
| Total Debt | 23.87B |
| Net Cash | -14.86B |
| Net Cash Per Share | -$12.30 |
| Equity (Book Value) | 84.20B |
| Book Value Per Share | 69.39 |
| Working Capital | 3.06B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $12.62 billion and capital expenditures -$2.07 billion, giving a free cash flow of $10.44 billion.
| Operating Cash Flow | 12.62B |
| Capital Expenditures | -2.07B |
| Free Cash Flow | 10.44B |
| FCF Per Share | $8.65 |
Full Cash Flow StatementMargins
Gross margin is 72.34%, with operating and profit margins of 20.66% and 16.72%.
| Gross Margin | 72.34% |
| Operating Margin | 20.66% |
| Pretax Margin | 12.89% |
| Profit Margin | 16.72% |
| EBITDA Margin | 27.05% |
| EBIT Margin | 20.66% |
| FCF Margin | 19.04% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 3.59%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 3.59% |
| Dividend Growth (YoY) | 8.13% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 21.36% |
| Buyback Yield | 2.43% |
| Shareholder Yield | 6.02% |
| Earnings Yield | 8.57% |
| FCF Yield | 9.76% |
Dividend DetailsAnalyst Forecast
The average price target for Sanofi is $61.50, which is 38.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $61.50 |
| Price Target Difference | 38.05% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 4.58% |
| EPS Growth Forecast (5Y) | 13.02% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
